Objects
Scurry, James, van Zyl, Belinda, Gulliver, Damien, Otton, Geoffrey, Jaaback, Kenneth, Lombard, Janine, Vilain, Ricardo E., Bowden, Nicola A.. Elsevier; 2018. Nucleotide excision repair protein ERCC1 and tumour-infiltrating lymphocytes are potential biomarkers of neoadjuvant platinum resistance in high grade serous ovarian cancer.
Tang, Monica, O'Connell, Rachel L., Amant, Frederic, Beale, Philip, McNally, Orla, Sjoquist, Katrin M., Grant, Peter, Davis, Alison, Sykes, Peter, Mileshkin, Linda, Moujaber, Tania, Kennedy, Catherine J., deFazio, Anna, Tan, King, Antill, Yoland, Goh, Jeffrey, Bonaventura, Tony, Scurry, James, Friedlander, Michael. Academic Press; 2019. PARAGON: a phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumors.
Bonaventura, Anthony, O'Connell, Rachel L., Martyn, Julie, DeFazio, Anna, Scurry, James, Friedlander, Michael L., Mapagu, Cristina, Beale, Philip J., McNally, Orla M., Mileshkin, Linda R., Grant, Peter T., Hadley, Alison M., Goh, Jeffery C. H., Sjoquist, Katrin M.. Lippincott Williams & Wilkins; 2017. Paragon (ANZGOG-0903): phase 2 study of Anastrozole in women with estrogen or progesterone receptor-positive platinum-resistant or -refractory recurrent ovarian cancer.
Mileshkin, Linda, Edmondson, Richard, O'Connell, Rachel L., Sjoquist, Katrin M., Andrews, John, Jyothirmayi, Rema, Beale, Philip, Bonaventura, Tony, Goh, Jeffrey, Hall, Marcia, Clamp, Andrew, Green, John, Lord, Rosemary, Amant, Frédéric, Alexander, Laura, Carty, Karen, Paul, James, Scurry, James, Millan, David, Nottley, Steven, Friedlander, Michael. Academic Press; 2019. Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: the PARAGON trial – ANZGOG 0903.
Mittal, Parul, Klingler-Hoffmann, Manuela, Hoffmann, Peter, Oehler, Martin K., Arentz, Georgia, Winderbaum, Lyron, Kaur, Gurjeet, Anderson, Lyndal, Scurry, James, Leung, Yee, Stewart, Colin J. R., Carter, Jonathan. Elsevier; 2017. Annexin A2 and alpha actinin 4 expression correlates with metastatic potential of primary endometrial cancer.
Mittal, Parul, Klingler-Hoffmann, Manuela, Carter, Jonathan, Kaur, Gurjeet, Oehler, Martin K., Hoffmann, Peter, Arentz, Georgia, Winderbaum, Lyron, Lokman, Noor A., Zhang, Chao, Anderson, Lyndal, Scurry, James, Leung, Yee, Stewart, Colin JR.. Wiley; 2016. Lymph node metastasis of primary endometrial cancers: Associated proteins revealed by MALDI imaging.